No Data
No Data
Healthcare Stocks at an 'Inflection Point,' Analyst Says
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
UnitedHealth Group Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 20.23% UBS $640 → $680 Maintains Buy 07/17/2024 6.09% Argus Research $570 → $600 Maintains
Market Whales and Their Recent Bets on UNH Options
Deep-pocketed investors have adopted a bullish approach towards UnitedHealth Group (NYSE:UNH), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
UnitedHealth Group (UNH) has an average rating of Buy and price targets ranging from $545 to $680, according to analysts polled by Capital IQ.Price: 570.64, Change: -2.64, Percent Change: -0.46
Express News | UnitedHealth Group Shares Hit Record High, Last up 1.3%
Ultratech : if that your real photo or guy in real life
被祝福的账户 : This analysis